Literature DB >> 12777098

Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.

Cao ShengFeng1, Lu Ping, Suen Tao, Wang Xin, Wang GuoFeng.   

Abstract

An active form of a single-chain antibody (scFv) from the murine monoclonal antibody (mAb) 1C7, which is specific for type O foot and mouth disease virus (FMDV), was produced in Escherichia coli. The complementary DNAs encoding the variable regions of the heavy chain (VH) and light chain (VL) were connected by a (Gly4Ser)3 linker, using an assembly polymerase chain reaction. VH-(Gly4Ser)3-VL genes were screened by phage display technology. The sequencing results showed that the VH gene of scFv was composed of germline VH76-1BG-DFL16.1-JH4 and the VL gene of scFv consisted of germline bw20-JK2. The resultant scFv gene was cloned to the pPRoEX HTc vector and expressed in E. coli as inclusion bodies. After extraction from the E. coli cells, the inclusion bodies were solubilized and denatured in the presence of 8 mol/L urea. The expressed scFv fusion proteins were purified by nickel-nitrilotriacetic acid and finally renatured by dialysis. The purity and activity of the purified scFv were confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and enzyme-linked immunosorbent assay. The result revealed that the 1C7 scFv conserved the same characteristics of specific recognition and binding to type O FMDV as the parental 1C7 mAb.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777098     DOI: 10.1023/a:1023300825438

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  27 in total

1.  Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells.

Authors:  J Li; Y Wang; Z Wang; Z Dong
Journal:  Immunol Lett       Date:  2000-03-01       Impact factor: 3.685

Review 2.  Advances in refolding of proteins produced in E. coli.

Authors:  H Lilie; E Schwarz; R Rudolph
Journal:  Curr Opin Biotechnol       Date:  1998-10       Impact factor: 9.740

3.  Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination.

Authors:  E Beck; K Strohmaier
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Phage-displayed and soluble mouse scFv fragments neutralize rabies virus.

Authors:  B H Muller; F Lafay; C Demangel; P Perrin; N Tordo; A Flamand; P Lafaye; J L Guesdon
Journal:  J Virol Methods       Date:  1997-09       Impact factor: 2.014

5.  Cloning and expression of a single-chain antibody fragment specific for foot-and-mouth disease virus.

Authors:  P Mason; A Berinstein; B Baxt; R Parsells; A Kang; E Rieder
Journal:  Virology       Date:  1996-10-15       Impact factor: 3.616

6.  Escherichia coli secretion of an active chimeric antibody fragment.

Authors:  M Better; C P Chang; R R Robinson; A H Horwitz
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

7.  Overexpression and purification of the sigma subunit of Escherichia coli RNA polymerase.

Authors:  M Gribskov; R R Burgess
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

8.  Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes.

Authors:  H Sakano; R Maki; Y Kurosawa; W Roeder; S Tonegawa
Journal:  Nature       Date:  1980-08-14       Impact factor: 49.962

9.  Conservation of cys-cys trp structural triads and their geometry in the protein domains of immunoglobulin superfamily members.

Authors:  T R Ioerger; C Du; D S Linthicum
Journal:  Mol Immunol       Date:  1999-04       Impact factor: 4.407

10.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

View more
  1 in total

Review 1.  Demystified...recombinant antibodies.

Authors:  K A Smith; P N Nelson; P Warren; S J Astley; P G Murray; J Greenman
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.